DOPAMINE HYDROCHLORIDE

Pre-Launch

ANDAINJECTIONINJECTABLE

Lifecycle

Pre-Launch

Data completeness

2/8 — Basic

DOPAMINE HYDROCHLORIDE by Smith and Nephew is 3,4 dihydroxyphenylalanine (dopa). Approved for hemodynamic status in patients in shock.

Drug data last refreshed 3h ago

Mechanism of Action

3,4 dihydroxyphenylalanine (DOPA). It is a precursor to norepinephrine in noradrenergic nerves and is also a neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal tract, and in a few peripheral sympathetic nerves. Dopamine elicits its pharmacological…

Indications (1)

hemodynamic status in patients in shock

Company

Worked on DOPAMINE HYDROCHLORIDE at Smith and Nephew? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.